Dopa decarboxylase genotypes may influence age at onset of schizophrenia
Open Access
- 23 October 2001
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 6 (6) , 712-717
Abstract
Several lines of evidence implicate dopa decarboxylase (DDC) with schizophrenia. By analysis of two putative functional DDC variants in 173 schizophrenic patients and 204 controls we tested the hypotheses that DDC is involved in: (1) predisposition to schizophrenia; and (2) modulation of age at disease onset. No association was observed with schizophrenia as a whole, whereas an association between DDC genotypes and age at disease onset was suggested in males (P = 0.03). This association was most pronounced in relation to genotypes of haplotypes comprising both variants, suggesting an additive model where one variant mediates early and the other late onset. Accordingly, the haplotype-based genotypes could be assigned into three groups by their possible relative effect on age at onset: an ‘early’, ‘neutral’ and ‘late’ group. Dividing the male schizophrenics into four groups with increasing age at onset, the ‘early’ genotypes were seen to decrease in frequency from 51.5% to 16.7% while the ‘late’ genotypes increased from 12.1% to 33.3% (P = 0.02). The difference in mean age at onset between male patients with ‘early’ genotypes vs patients with ‘late’ genotypes was close to 5 years (95% CI: 0.7–8.8). Thus, DDC may possibly act as a modulator of age at onset in male schizophrenics.Keywords
This publication has 26 references indexed in Scilit:
- Amphetamine and vigabatrin down regulate aromatic l-amino acid decarboxylase mRNA levelsMolecular Brain Research, 1996
- Schizophrenia: developmental neuroscience and pathobiologyThe Lancet, 1993
- Long-term Course of Hospitalization for Schizophrenia: Part I. Risk for RehospitalizationSchizophrenia Bulletin, 1992
- An animal model for the effects of estradiol on dopamine-mediated behavior: Implications for sex differences in schizophreniaPsychiatry Research, 1991
- Plasma phenylethylamine in schizophrenic patientsBiological Psychiatry, 1991
- Phenylacetic acid in CSF and serum in Indian schizophrenic patientsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1991
- The spectrum of structural brain changes in schizophrenia: age of onset as a predictor of cognitive and clinical impairments and their cerebral correlatesPsychological Medicine, 1989
- Response to drugs in schizophrenia: the influence of family history, obstetric complications and ventricular enlargementPsychological Medicine, 1988
- Schizophrenia with Good and Poor Outcome. I: Early Clinical Features, Response to Neuroleptics and Signs of Organic DysfunctionThe British Journal of Psychiatry, 1985
- Analytic Considerations about Observed Distribution of Age of Onset in SchizophreniaNeuropsychobiology, 1982